Administrative and Coordinating Core

行政协调核心

• 批准号: 10689735
• 负责人: MARGARET M MADELEINE
• 金额: $ 32.91万
• 依托单位: FRED HUTCHINSON CANCER CENTER
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-18 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10689735
• 关键词: Acceleration; Accountability; Adoption; Advocate; Biological Assay; CLC Gene; Cancer Burden; Caribbean region; Cessation of life; Child; Clinical; Clinical Services; Clinical Trials; Communication; Communities; Country; Credentialing; Data; Dominican Republic; Fostering; Goals; Grant; Guidelines; HIV; Heart; Human Papilloma Virus-Related Malignant Neoplasm; Human Papillomavirus; Human papilloma virus infection; Income; Information Dissemination; Infrastructure; Institution; International; Interruption; Laboratories; Laboratory Procedures; Latin American; Lead; Leadership; Lesion; Malignant neoplasm of cervix uteri; Methods; Modeling; Monitor; Outcome; Paper; Periodicals; Persons; Peru; Policies; Population; Preventative vaccination; Prevention; Primary Prevention; Problem Solving; Productivity; Protocols documentation; Publications; Publishing; Qualifying; Quality Control; Records; Reporting; Research; Research Personnel; Resources; Risk; Safety; Schedule; Science; Scientific Advances and Accomplishments; Secondary Prevention; Services; Site; Structure; Training; Translating; Triage; Update; Vaccination; Woman; Work; cancer prevention; cancer risk; cervical cancer prevention; co-clinical trial; data management; experience; human subject; improved; meetings; member; novel strategies; participant safety; patient safety; premalignant; prevent; recruit; screening; skills training; success; tertiary prevention; tool

The overarching goal of the Administrative and Coordinating Core (ACC) is to provide effective leadership to optimize the successful accomplishment of the scientific aims of the Cervical Cancer Prevention Partnership (C2P2) Center in Peru and the Dominican Republic. The management team for the ACC includes three investigators: a Peru-based investigator, Dr. Robinson Cabello, MPI, and two Seattle-based investigators, Dr. Duerr (MPI and Co-Chair Trial 1) and Dr. Madeleine (Contact MPI, Co-Investigator Trials 2 and 3). Together they will provide scientific direction, enhance productivity, liaise with the NCI, and monitor safety, quality, recruitment, and progress toward each of the Aims of the Clinical Trials and service Cores. The Aims of the ACC are as follows: Aim 1 of the ACC is to organize the C2P2 Center by distributing responsibility and accountability throughout the C2P2 Center. The ACC will implement the Triple C (Communication, Cooperation and Coordination) model of project management. This organizational approach will be grounded in meeting regional needs and in respect for working with LAC partners who will lead and sustain the cuttingedge changes we develop together through integrated and interdisciplinary team science. Aim 2 is to facilitate communication and scheduling at all levels of the partnership. The ACC will foster high-level and bidirectional coordination and cooperation directly with unit leaders (Clinical Trial Co-Chairs and service Core Leaders) across the C2P2 Center (i.e., Core teams, Clinical Trial teams, institutions), and with external advisors (i.e., External Scientific Advisory Group and the cross-cutting Partnership Center Coordinating Committee). Aim 3 of the ACC is to lead all trial monitoring and regulatory coordination activities with the assistance of the Data Coordinating Core. The first priority of the ACC is patient safety at both trial sties. Aim 4 of the ACC will provide training and dissemination of findings. The ACC will administratively support the Clinical Trial Co-Chairs through cross-institutional training as needed to refine laboratory assay quality control, data management skills training, and streamlined organizational infrastructure building that will enhance the success of the matrixed partnership. All trial findings will be disseminated through published papers and presentations in the region and at international meetings of policy and guideline makers who will be able to use our trial findings to accelerate progress toward elimination of cervical cancer through prevention. The ACC will provide leadership to accomplish the overall scientific goal of the C2P2 Center to improve the quality and efficiency of cervical cancer prevention in the region.

行政和协调核心(行政协调会)的首要目标是提供有效领导 优化宫颈癌预防科学目标的顺利实现 秘鲁和多米尼加共和国的伙伴关系(C2P2)中心。行政协调会的管理团队包括 三名调查员：一名秘鲁调查员、MPI的Robinson Cabello博士和两名西雅图调查员 调查员，Duerr博士(MPI和联合主席试验1)和Madeleine博士(联系MPI，联合调查员试验2) 和3)。他们将共同提供科学指导，提高生产率，与NCI联系，并监测 安全、质量、招募和朝着临床试验和服务核心的每一个目标的进展。这个 ACC的目标如下：ACC的目标1是通过分配职责来组织C2P2中心 和整个C2P2中心的责任。ACC将实施Triple C(通信、 合作与协调)项目管理模式。这一组织方法将是有根基的 在满足区域需求方面，并尊重与拉丁美洲和加勒比地区合作伙伴的合作，这些伙伴将领导和维持我们通过综合和跨学科团队科学共同发展的前沿变革。目标2是为了促进 在伙伴关系的所有级别进行沟通和安排。ACC将直接与单位领导(临床试验联合主席和服务核心)促进高级别和双向协调与合作 C2P2中心(即核心团队、临床试验团队、机构)和外部 顾问(即外部科学咨询小组和跨领域伙伴关系中心协调 委员会)。行政协调委员会的目标3是领导所有试验监测和监管协调活动 数据协调核心的协助。ACC的首要任务是确保两个试验中心的患者安全。目标4 行政协调会将提供培训和传播调查结果。行政协调委员会将在行政上支持 临床试验联席主席根据需要通过跨机构培训来完善实验室分析质量控制， 数据管理技能培训和精简的组织基础设施建设，这将增强 母公司合作关系的成功。所有试验结果将通过发表的论文和 在该区域和在政策和指导方针制定者的国际会议上发表演讲，这些人将能够使用 我们的试验结果旨在加快通过预防消除宫颈癌的进展。行政协调委员会将 为实现C2P2中心的总体科学目标提供领导，以提高质量和 该地区宫颈癌预防工作的成效。